(Q40433282)

20 September 2017

1 reference

title

T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes (English)

1 reference

20 September 2017

T‐Cell Immunotherapy of Tumors by Adoptive Transfer of Cytotoxic T Lymphocytes and by Vaccination with Minimal Essential Epitopes (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

30 May 2024

2

W. M. Kast

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590825

30 May 2024

author name string

C. J. Melief

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7590825

30 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7590825

30 May 2024

publication date

1 June 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-065X.1995.tb00081.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-065X.1995.tb00081.x

30 May 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

30 May 2024

published in

Immunological Reviews

1 reference

20 September 2017

volume

145

1 reference

20 September 2017

page(s)

167-177

1 reference

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Potential immunogenicity of oncogene and tumor suppressor gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

p53, a potential target for tumor-directed T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1995.TB00081.X

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/EJI.1830230929

Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Detailed motifs for peptide binding to HLA-A*0201 derived from large random sets of peptides using a cellular binding assay

30 May 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

30 May 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

30 May 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccination

30 May 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide

30 May 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Tumor eradication by adoptive transfer of cytotoxic T lymphocytes

30 May 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Lessons from T cell responses to virus induced tumours for cancer eradication in general

30 May 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Prospects for T cell immunotherapy of tumours by vaccination with immunodominant and subdominant peptides

30 May 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Biology and biochemistry of papillomaviruses

30 May 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

30 May 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein

30 May 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Peptide-induced antiviral protection by cytotoxic T cells

30 May 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice.

30 May 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein

30 May 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Interleukin 12: a key modulator of immune function

30 May 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

30 May 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

Human papillomaviruses in the pathogenesis of anogenital cancer

30 May 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-065X.1995.TB00081.X

30 May 2024

Identifiers

1 reference

20 September 2017

1 reference